Clipping of news on Brazilian Culture, Law and Citizenship
03/28/2012
This article was translated by an automatic translation system, and was therefore not reviewed by people.
Specialist insisted that diabetes is a cardiovascular risk factor
Bariatric surgery to restrict food intake seems to be the only salvation for people with overweight and obesity with diabetes, according to two studies published on Tuesday.
The first study, called Stampede, was made in the United States with 150 people in different degrees of obesity and presented at the annual conference of the American College of Cardiology (ACC, its acronym in English).
The second study was made in Italy with 60 diabetic overweight or obese between the ages of 30 and 60 years.
The two trials were published simultaneously in the digital version of the medical journal New England Journal of Medicine.
"For almost a century to treat diabetes with pills and injections (insulin) and the study Stampede is one of the first to demonstrate that bariatric surgery in some patients could be much more effective than drugs," said Philip Schauer, professor of surgery the Cleveland Clinic (Ohio, U.S.), who led this trial.
It is called the set of bariatric surgery to treat obesity.
The expert also stressed that diabetes, an epidemic is an important cardiovascular risk factor.
Stampede for the study, 150 participants, 66% women, mean age 49 years, were divided into three groups.
The first was subjected to an intensive medical treatment that combined exercise, diet and medication.
The second group, and taking medications for diabetes, underwent surgery for a 'bypass' stomach, which resulted in stomach reduction of 2% or 3% of its original volume and creating a diversion in the digestive tract to reduce food absorption.
The third group, and taking medication, was subjected to gastrectomy to reduce the volume of the stomach between 75% and 80%.
A year later, participants who had undergone one or other bariatric procedures had three to four times more likely to control their diabetes than the control group.
Furthermore, patients in the last two groups have lost much more weight and reduced their dependence on drugs against diabetes.
"The improvement between the two who underwent surgery was so quick that many patients can stop taking medication for diabetes before leaving the hospital," said Schauer.
He said this approach could represent major changes in the treatment of some diabetic patients, many of which never managed to control the disease.
The results of the second clinical study, done by Mingrone Geltrude, Catholic University of Rome, were also encouraging.
Two years after interventions, there was no type in remission of diabetes control group. In contrast, 75% of people who underwent surgery 'bypass' gastric and 95% who underwent other surgical procedures have overcome diabetes.
For Schauer, the results suggest that even patients who are obese could actually benefit from these interventions.
But the surgeries are not without risk, the expert continued, noting a higher rate of complications in both groups.
In an editorial published in the journal The New England Journal of Medicine, Paul Zimmet, the Baker Institute of Diabetes and the Heart of Melbourne (Australia) said that "these two studies probably revolutionize the treatment of diabetes."
Source: The Day on Line
Our news are taken in full of our partner sites. For this reason, we can not change the content of these up in case of typing errors.
This article was translated by an automatic translation system, and was therefore not reviewed by people.